Call 7
TOPIC 1: VALIDATION OF TRANSLATIONAL IMAGING METHODS IN DRUG SAFETY ASSESSMENT (TRISTAN)
TOPIC 2: IDENTIFICATION OF DRUGGABLE TARGETS MODULATING MISFOLDED PROTEINS IN ALZHEIMER’S AND PARKINSON’S DISEASES
TOPIC 3: PATHOLOGICAL NEURON-GLIA INTERACTIONS IN NEUROPATHIC PAIN
TOPIC 4: DRY AGE-RELATED MACULAR DEGENERATION: DEVELOPMENT OF NOVEL CLINICAL ENDPOINTS FOR CLINICAL TRIALS WITH A REGULATORY AND PATIENT ACCESS INTENTION
TOPIC 5: A COMPREHENSIVE ‘PAEDIATRIC PRECLINICAL POC PLATFORM’ TO ENABLE CLINICAL MOLECULE DEVELOPMENT FOR CHILDREN WITH CANCER
INTRODUCTION TO THE IMI2 BIG DATA FOR BETTER OUTCOMES PROGRAMME (BD4BO)
TOPIC 6: COORDINATION AND SUPPORT ACTIONS (CSA) FOR THE BIG DATA FOR BETTER OUTCOMES PROGRAMME
TOPIC 7: INCREASE ACCESS AND USE OF HIGH QUALITY DATA TO IMPROVE CLINICAL OUTCOMES IN HEART FAILURE (HF), ATRIAL FIBRILLATION (AF), AND ACUTE CORONARY SYNDROME (ACS) PATIENTS
Key dates
Publication date: 18 December 2015
Stage 1 submission start date: 18 December 2015
Stage 1 submission deadline: 17 March 2016 – 17:00:00 Brussels time
Call 8
Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks
Key dates
Publication date: 18 December 2015
This call for proposals is continuously open for a period of two years with the following cut-off dates for submission of proposals:
16 March 2016, 15 September 2016, 16 March 2017, 14 September 2017, 15 March 2018.
